AR and partial androgen insensitivity syndrome: As a result, they reported a new class of individuals who were Androgen Receptor (AR) mutation negative but had a PAIS phenotype, who could be reliably identified using transcriptional induction of an AR target protein, apolipoprotein D (APOD) [15].